benzbromarone has been researched along with Sensitivity and Specificity in 3 studies
Benzbromarone: Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.
benzbromarone : 1-Benzofuran substituted at C-2 and C-3 by an ethyl group and a 3,5-dibromo-4-hydroxybenzoyl group respectively. An inhibitor of CYP2C9, it is used as an anti-gout medication.
Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwamura, A | 1 |
| Fukami, T | 1 |
| Hosomi, H | 1 |
| Nakajima, M | 1 |
| Yokoi, T | 1 |
| Locuson, CW | 2 |
| Wahlstrom, JL | 1 |
| Rock, DA | 3 |
| Jones, JP | 2 |
3 other studies available for benzbromarone and Sensitivity and Specificity
| Article | Year |
|---|---|
CYP2C9-mediated metabolic activation of losartan detected by a highly sensitive cell-based screening assay.
Topics: Antihypertensive Agents; Aryl Hydrocarbon Hydroxylases; Benzbromarone; Biotransformation; Cyclooxyge | 2011 |
A new class of CYP2C9 inhibitors: probing 2C9 specificity with high-affinity benzbromarone derivatives.
Topics: Aryl Hydrocarbon Hydroxylases; Benzbromarone; Binding Sites; Cytochrome P-450 CYP2C9; Molecular Prob | 2003 |
Quantitative binding models for CYP2C9 based on benzbromarone analogues.
Topics: Aryl Hydrocarbon Hydroxylases; Benzbromarone; Binding Sites; Cytochrome P-450 CYP2C9; Enzyme Inhibit | 2004 |